Research and Development

Showing 15 posts of 9604 posts found.

Roche antibody becomes first of its kind authorised for blood cancer

July 26, 2017 Research and Development, Sales and Marketing CDF, Cancer, NICE, drugs, lymphoma, pharma, pharmaceutical Roche

NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …
janssen_latest_logo_on_sign

Janssen single tablet regimen shows Phase 3 success in HIV

July 26, 2017 Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals

The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …

Celgene agrees one of the largest settlements for false claims on record

July 26, 2017 Research and Development, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical, thalomid

It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …

Further evidence of NHS recruitment crisis as vacancies skyrocket

July 25, 2017 Medical Communications, Research and Development NHS, biotech, drugs, midwifery, nursing, pharma, pharmaceutical

Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …

Lilly snaps up autoimmune drug in $400m biotech partnership

July 25, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma

Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …
erard_gilles

Context Therapeutics add new CMO

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Context Therapeutics, biotech, drugs, pharma, pharmaceutical

Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …

Wave expands editorial and programme delivery teams with two appointments

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, pharma, pharmaceutical

Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …
british_pharmacopeia

The British Pharmacopoeia 2018 now available

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Pharmacopoeia, biotech, drugs, healthcare, pharma, pharmaceutical

The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …

Monthly injectable HIV treatment proves as effective as traditional daily pill regimen

July 24, 2017 Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals

New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
laurie-glimcher-large

GSK unveil appointment coup for board of directors

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, GSK, biotech, drugs, immunooncology, pharma, pharmaceutical

GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
blood-1813410_960_720

Blood test developed for early Alzheimer’s detection

July 20, 2017 Medical Communications, Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical

A blood test has been created that could offer an inexpensive, and less invasive, alternative to current Alzheimer’s disease tests. …
dr-nathan-brown

BenevolentAI installs new Head of Cheminformatics

July 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

BenevolentAI, a company that uses an artificial intelligence platform to improve drug discovery, has announced the appointment of Nathan Brown …
smaller_size

Pushing the value of data

July 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Ray, NHS, NHS Digital, biotech, drugs, pharma, pharmaceutical

Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital …
nhs_parliament_2_4

Cost-cutting not the way to drive value for the NHS, finds independent committee

July 19, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without …
The Gateway to Local Adoption Series

Latest content